Quartz 4
Search
Search
Dark mode
Light mode
Explorer
Tag: antibody-antigen-interactions/misc
15 items with this tag.
Apr 21, 2026
Affinity maturation causes antibody-antigen interfaces to be more similar to generic PPI interfaces
affinity-maturation
protein-protein-interactions
antibody-antigen-interactions/misc
Apr 21, 2026
Affinity matured antibodies can adopt distinct binding poses from germline precursors
affinity-maturation
antibody-antigen-interactions/misc
Apr 21, 2026
Antibodies from different repertoires within a given species targeting the same epitope often have the same light chain isotype and share critical residues
affinity-maturation/somatic-hypermutation
antibody-antigen-interactions/misc
Apr 21, 2026
Antibody-antigen binding modes are not necessarily defined by induced fit
protein-protein-interactions
antibody-antigen-interactions/misc
Apr 21, 2026
CDR3 far more likely to be part of paratope of nanobodies compared to antibodies
cdrh3
antibody-antigen-interactions/misc
Apr 21, 2026
CDR3 loops encode specificity while CDR1 and CDR2 encode cross-reactivity
antibody-developability/polyspecificity
cdrh3
antibody-antigen-interactions/misc
Apr 21, 2026
CDRH3 conformational rigidity reduces cross reactivity
cdrh3
antibody-developability/polyspecificity
antibody-antigen-interactions/misc
Apr 21, 2026
CDRH3 has most contacts with antigen
cdrh3
protein-protein-interactions
antibody-antigen-interactions/misc
Apr 21, 2026
CDRH3 is necessary but insufficient to guarantee binding to a particular epitope
cdrh3
antibody-antigen-interactions/misc
Apr 21, 2026
Changes to hydrophobicity and charge correlate with antibody escape
antibody-developability/hydrophobicity
antibody-antigen-interactions/misc
Apr 21, 2026
Conformational entropy in antibodies decreases during affinity maturation
affinity-maturation
conformational-dynamics/evolution
citation-fix
antibody-antigen-interactions/misc
Apr 21, 2026
Most nanobodies do not bind using all three CDRs
antibodies/nanobodies
antibody-antigen-interactions/misc
Apr 21, 2026
Nanobodies and Abs target different epitopes but with similar accessibility and number of contacts
antibodies/nanobodies
antibody-antigen-interactions/misc
Apr 21, 2026
Nanobody framework residues more likely to be part of paratope than those of antibodies
antibodies/nanobodies
antibody-antigen-interactions/misc
Apr 21, 2026
Up to 22 percent of antigen binding residues are outside CDRs
antibody-antigen-interactions/misc